[email protected]

CGTN: Xizang’s development is a story of transformation and renewal

by

CGTN: Xizang’s development is a story of transformation and renewal CGTN: Xizang’s development is a story of transformation and renewalBEIJING, Aug. 19, 2025 (GLOBE NEWSWIRE) — The story of today’s Xizang Autonomous Region can’t be told in isolation. The profound transformation, resilience and renewal that people see today are a stark departure from the dark … Read more

Bitget Opens Access for AI Agent-Assisted Trading Boosting Wider Crypto Adoption

by

Bitget Opens Access for AI Agent-Assisted Trading Boosting Wider Crypto Adoption Bitget Opens Access for AI Agent-Assisted Trading Boosting Wider Crypto Adoption VICTORIA, Seychelles, Aug. 19, 2025 (GLOBE NEWSWIRE) — Bitget, the leading cryptocurrency exchange and Web3 company, has announced its AI-powered trading assistant, GetAgent, is now available to all users. First introduced in July in an … Read more

Nyxoah Reports Second Quarter Financial and Operating Results

by

REGULATED INFORMATION Nyxoah Reports Second Quarter Financial and Operating Results FDA Approves Genio® System for U.S. Market; Company Begins Commercial Launch Mont-Saint-Guibert, Belgium – August 18, 2025, 10:10pm CET / 4:10 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea … Read more

24/7 concierge: Zoom’s agentic AI and virtual agent now extends to Zoom Phone, helping businesses capture more calls and opportunities

by

Zoom Virtual Agent expands to Zoom Phone, enabling a new concierge use case that delivers personalized support with agentic concierge capabilities to automate routine calls and streamline frontline service across departments Zoom AI Companion enhances agentic scheduling to coordinate meetings end-to-end, finding the best time, contacting attendees, tracking responses, and recommending next steps without the … Read more

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

by

Extrovis AG Bahnhof Park 4 6340, Baar, Switzerland Media Relations Contact Madhu Marur [email protected] Press Release Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy’s Laboratories … Read more

Lantronix Solution Powers U.S. Army-Approved Teal Drones, a Red Cat Holdings Co., Unlocking Secure Edge AI Growth Opportunity

by

Lantronix Enables TAA- and NDAA-Compliant Edge AI Solution, Supporting Sensitive U.S. Government Missions and Expanding Long-Term Defense Market Positioning IRVINE, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that its TAA- and NDAA-compliant solution was selected by … Read more

BTCS Offers Shareholders a $0.05 per share “Bividend” – a Blockchain Dividend Payable in Ethereum

by

Offers shareholders an additional $0.35 per share Ethereum Loyalty Payment for moving shares to Book Entry SILVER SPRING, MD, Aug. 18, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that it is paying shareholders a one-time blockchain dividend, or … Read more

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Lockheed Martin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – LMT

by

NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lockheed Martin Corporation (NYSE: LMT) between January 23, 2024 and July 21, 2025, both dates inclusive (the “Class Period”), of the important September 26, 2025 lead plaintiff deadline. SO WHAT: If you purchased Lockheed Martin … Read more